首页> 外文期刊>International Journal of Basic & Clinical Pharmacology >Assessment of drug utilization pattern and rationality of drug use in treatment of dilated cardiomyopathy in a tertiary care teaching hospital of rural Bengal
【24h】

Assessment of drug utilization pattern and rationality of drug use in treatment of dilated cardiomyopathy in a tertiary care teaching hospital of rural Bengal

机译:孟加拉农村三级教学医院对扩张型心肌病的用药模式和用药合理性评估

获取原文
       

摘要

Background: Dilated cardiomyopathy (DCM) is an important underlying cause of congestive heart failure and/or arrhythmias. The introduction of therapy combining diuretics, digoxin and angiotensin converting enzyme inhibitors (ACEI) has significantly decreased mortality and morbidity. The aim of the study was undertaken to identify the pattern of drugs most commonly prescribed for DCM and to assess the rationality behind such use. Methods: This was a prospective study undertaken between 1st July and 31st August 2015. Prescriptions were reviewed and analyzed using the World Health Organization (WHO) indicators for drug utilization studies. Rationality and cost of therapy per prescription was also evaluated. Results: We encountered 78 patients of DCM in the OPD of Cardiology (prevalence of 4.94%). The average number of drugs per prescription was 6.64. Generic prescriptions were made in 90% encounters. As part of therapy, diuretics and ACE inhibitors or angiotensin receptor blockers, were prescribed in all cases. Our results show a distinctive drug use pattern where beta blockers were used more commonly than digoxin. Other commonly prescribed agents were antiplatelet drugs and statins. Antibiotics were prescribed in 8.7% cases and no injectable drug was prescribed. Average drug cost per encounter was 10.63 INR. Conclusions: To conclude, we found a typical and rational pattern of drug use. Diuretics, ACEI and beta blockers were found to be most commonly used agents. This study provides a clear picture of drug use in this special clinical condition in rural Bengal and paves the way for larger and long term studies.
机译:背景:扩张型心肌病(DCM)是导致充血性心力衰竭和/或心律不齐的重要根本原因。利尿剂,地高辛和血管紧张素转化酶抑制剂(ACEI)联合治疗的引入大大降低了死亡率和发病率。进行研究的目的是确定最常用于DCM的药物类型,并评估其使用的合理性。方法:这是一项于2015年7月1日至8月31日进行的前瞻性研究。使用世界卫生组织(WHO)的药物利用指标对处方进行了审查和分析。还评估了每个处方的合理性和治疗费用。结果:我们在心脏病学领域的OPD中遇到了78例DCM患者(患病率为4.94%)。每个处方药的平均数量为6.64。普通处方是在90%的遭遇中做出的。作为治疗的一部分,在所有情况下都处方了利尿剂和ACE抑制剂或血管紧张素受体阻滞剂。我们的研究结果表明,与地高辛相比,β受体阻滞剂的使用更为普遍。其他常用处方药是抗血小板药和他汀类药物。在8.7%的病例中开了抗生素,没有开注射药。每次遭遇的平均药物费用为10.63 INR。结论:总而言之,我们发现了一种典型的合理用药模式。发现利尿剂,ACEI和β受体阻滞剂是最常用的药物。这项研究清楚地显示了孟加拉农村地区这种特殊临床情况下的药物使用情况,为大规模和长期研究铺平了道路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号